IOSP vs TBBK
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
IOSP · Innospec$78.21 ▼ 1.16%
TBBK · The Bancorp$48.25 ▲ 1.07%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- IOSP +6.7%
- TBBK -22.7%
Head to head
| Metric | IOSP | TBBK |
|---|---|---|
| Price | $78.21 | $48.25 |
| Change today | ▼ 1.16% | ▲ 1.07% |
| Market cap | $1.93B | $1.93B |
| Return, 3 months | -15.8% | -30.0% |
| Return, year to date | +3.4% | -28.5% |
| Return, 1 year | +4.8% | -22.5% |
| P/E (TTM) | 13.8 | 8.5 |
| P/B | 1.4 | 2.8 |
| P/E percentile vs own 5y | 44th | 0th |
| Dividend yield | 2.29% | – |
| Revenue growth (YoY, latest qtr) | +11.8% | +0.7% |
| Net profit growth (YoY) | +30.5% | +14.3% |
| Gross margin | 27.5% | – |
| Operating margin | 8.1% | – |
| Net margin | 6.6% | 35.6% |
| Return on equity | 9.2% | 33.0% |
| Analyst target vs. price | +40.6% | +56.1% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 18 | 43 |
| 30-day volatility | 62.2% | 32.5% |
| Max drawdown, 1 year | -25.5% | -41.7% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- TBBK is the largest of the group by market value.
- IOSP has returned the most over the past year.
- TBBK carries the lowest trailing P/E.
- IOSP is growing revenue fastest.
- TBBK keeps the most profit per dollar of sales.
- TBBK has been the calmest stock over the last 30 days.